ArticleMetabolism open2021
COVID-19 vaccines: Current evidence and considerations.
Article in Metabolism open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.
- COVID-19 vaccine hesitancy in Ethiopia: a scoping review for equitable vaccine access.Frontiers in health services · 2025Pooled it
- Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis.PloS one · 2022Pooled it
- Pregnancy intention, preconception health, health behaviours, and information and health advice seeking among expectant male partners.BMC primary care · 2025Article
- Gender, Age and COVID-19 Vaccination Status in African American Adult Faith-Based Congregants in the Southeastern United States.Journal of racial and ethnic health disparities · 2024Article
- Article
- Attitudes and Acceptance of the Palestinian Population Towards COVID-19 Health Precautions and Vaccinations: A Cross-Sectional Study.Endocrine, metabolic & immune disorders drug targets · 2024Observational
- Perspectives in vaccines, immune response, therapeutic interventions and COVID-19.Metabolism open · 2023Article
- COVID-19 vaccinations and their side effects: a scoping systematic review.F1000Research · 2023Article
- The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic.Frontiers in medicine · 2023Article
- Web-Based Reporting of Post-Vaccination Symptoms for Inactivated COVID-19 Vaccines in Jordan: A Cross-Sectional Study.Vaccines · 2022Article
- Cambodia achieved a high vaccination coverage for its population: A good example of a lower middle-income country.Journal of global health · 2022Article
- Review
- Signs, Symptoms, and Side-Effects Presented by Different Types of COVID-19 Vaccines: A Prospective Cohort Study.Life (Basel, Switzerland) · 2022Article
- Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis Patients.Kidney international reports · 2022Article
- Humoral Immune Response of BNT162b2 and CoronaVac Vaccinations in Hemodialysis Patients: A Multicenter Prospective Cohort.Vaccines · 2022Article
- Development of DNA Vaccine Candidate against SARS-CoV-2.Viruses · 2022Article
- The COVID-19 pandemic in the African continent.BMC medicine · 2022Article
- Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2.Metabolism open · 2022Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic is a global crisis, with devastating health, business and social impacts. Vaccination is a safe, simple, and effective way of protecting a person against COVID-19. By the end of August 2021, only 24.6% of the world population has received two doses of a COVID-19 vaccine. Since the emergence of COVID-19, several COVID-19 vaccines have been developed and approved for emergency use. Current vaccines have shown efficacy with low risk of adverse effects. However, COVID-19 vaccines have been related to a relatively small number of cases of heart inflammation, anaphylaxis (allergic reactions), and blood clots formation. On the other hand, COVID-19 vaccination is not recommended for children less than 12 years of age. Furthermore, It has been proposed that some new variants (e.g., Lambda and Delta) are proficient in escaping from the antiviral immunity elicited by vaccination. Herein we present current considerations regarding the COVID-19 vaccines including: efficacy against new variants, challenges in distribution, disparities in availability, dosage gender and race difference, COVID-19 vaccine transport and storage, limitations in children and pregnant women. Long-time monitoring is essential in order to find vaccine efficacy and to rule out related side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.